IVERIC bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IVERIC bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to 2022.
  • IVERIC bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $2.59M, a 24.5% increase year-over-year.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $429M, a 57.5% increase from 2021.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $272M, a 80.9% increase from 2020.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $151M, a 252% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $429M +$157M +57.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $272M +$122M +80.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $151M +$108M +252% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $42.8M +$36.7M +598% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $6.14M +$6.07M +8548% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 $71K -$6.86M -99% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $6.93M -$5.84M -45.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $12.8M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.